149 related articles for article (PubMed ID: 10599548)
21. Transactivation of progestin- and estrogen-responsive promoters by 19-nor progestins in African Green Monkey Kidney CV1 cells.
Pasapera AM; Gutiérrez-Sagal R; García-Becerra R; Ulloa-Aguirre A; Savouret JF
Endocrine; 2001 Dec; 16(3):217-25. PubMed ID: 11954666
[TBL] [Abstract][Full Text] [Related]
22. Preclinical evaluation of norgestimate, a progestin with minimal androgenic activity.
Phillips A; Hahn DW; McGuire JL
Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1191-6. PubMed ID: 1415445
[TBL] [Abstract][Full Text] [Related]
23. Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate.
al-Azzawi F; Wahab M; Thompson J; Pornel B; Hirvonen E; Ylikorkala O; van der Mooren MJ; Dillon J; Magaril C
Climacteric; 2001 Dec; 4(4):343-54. PubMed ID: 11770191
[TBL] [Abstract][Full Text] [Related]
24. Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines.
Schoonen WG; Joosten JW; Kloosterboer HJ
J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):423-37. PubMed ID: 8541240
[TBL] [Abstract][Full Text] [Related]
25. [Promegestone, a new progestin].
Raynaud JP; Ojasoo T
J Gynecol Obstet Biol Reprod (Paris); 1983; 12(7):697-710. PubMed ID: 6366037
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of hormonal and antihormonal action of contraceptive progestins at the molecular level.
Pérez-Palacios G; Cerbón MA; Pasapera AM; Castro JI; Enríquez J; Vilchis F; García GA; Moralí G; Lemus AE
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):479-85. PubMed ID: 1562519
[TBL] [Abstract][Full Text] [Related]
27. Endocrinological studies with desogestrel.
van der Vies J; de Visser J
Arzneimittelforschung; 1983; 33(2):231-6. PubMed ID: 6221730
[TBL] [Abstract][Full Text] [Related]
28. Medroxyprogesterone acetate: receptor binding and correlated effects on steroidogenesis in rat granulosa cells.
Pridjian G; Schmit V; Schreiber J
J Steroid Biochem; 1987 Mar; 26(3):313-9. PubMed ID: 2953940
[TBL] [Abstract][Full Text] [Related]
29. Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer.
Teulings FA; van Gilse HA; Henkelman MS; Portengen H; Alexieva-Figusch J
Cancer Res; 1980 Jul; 40(7):2557-61. PubMed ID: 6248208
[TBL] [Abstract][Full Text] [Related]
30. Assessment of the potency of orally administered progestins in women.
King RJ; Whitehead MI
Fertil Steril; 1986 Dec; 46(6):1062-6. PubMed ID: 2946605
[TBL] [Abstract][Full Text] [Related]
31. Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats.
Laws SC; Carey SA; Ferrell JM; Bodman GJ; Cooper RL
Toxicol Sci; 2000 Mar; 54(1):154-67. PubMed ID: 10746942
[TBL] [Abstract][Full Text] [Related]
32. New progestagens for contraceptive use.
Sitruk-Ware R
Hum Reprod Update; 2006; 12(2):169-78. PubMed ID: 16291771
[TBL] [Abstract][Full Text] [Related]
33. Inhibitors and activation markers of the haemostatic system during hormone therapy: a comparative study of oral estradiol (2 mg)/ dydrogesterone and estradiol (2 mg)/ trimegestone.
Norris LA; Brosnan J; Bonnar J; Conard J; Kluft C; Hellgren M
Thromb Haemost; 2008 Aug; 100(2):253-60. PubMed ID: 18690345
[TBL] [Abstract][Full Text] [Related]
34. Assessment of oestrogen and progestin effects on epithelium and stroma from pre- and postmenopausal endometria.
King RJ; Lane G; Siddle N; Taylor RW; Townsend PT; Whitehead MI
J Steroid Biochem; 1981 Dec; 15():175-81. PubMed ID: 7339244
[TBL] [Abstract][Full Text] [Related]
35. Steroid receptor profiling of vinclozolin and its primary metabolites.
Molina-Molina JM; Hillenweck A; Jouanin I; Zalko D; Cravedi JP; Fernández MF; Pillon A; Nicolas JC; Olea N; Balaguer P
Toxicol Appl Pharmacol; 2006 Oct; 216(1):44-54. PubMed ID: 16750840
[TBL] [Abstract][Full Text] [Related]
36. Demonstration of steroid hormone receptors and steroid action in primary cultures of rat glial cells.
Jung-Testas I; Renoir M; Bugnard H; Greene GL; Baulieu EE
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):621-31. PubMed ID: 1562533
[TBL] [Abstract][Full Text] [Related]
37. Arachidonic acid as a possible modulator of estrogen, progestin, androgen, and glucocorticoid receptors in the central and peripheral tissues.
Kato J
J Steroid Biochem; 1989; 34(1-6):219-27. PubMed ID: 2516582
[TBL] [Abstract][Full Text] [Related]
38. [Pharma-Clinics. Medication of the month. Totelle Cycle: new sequential estrogen/progesterone regimen for hormone replacement therapy in menopause].
Gaspard U
Rev Med Liege; 2002 Jun; 57(6):408-12. PubMed ID: 12180037
[TBL] [Abstract][Full Text] [Related]
39. Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy.
DeManno D; Elger W; Garg R; Lee R; Schneider B; Hess-Stumpp H; Schubert G; Chwalisz K
Steroids; 2003 Nov; 68(10-13):1019-32. PubMed ID: 14667995
[TBL] [Abstract][Full Text] [Related]
40. Contribution of functional groups of 19-nor-progestogens to binding to progesterone and estradiol-17beta receptors in rabbit uterus.
Tamaya T; Nioka S; Furuta N; Shimura T; Takano N
Endocrinology; 1977 Jun; 100(6):1579-84. PubMed ID: 858280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
